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ABSTRACT
This work aims to develop functionalized, water-soluble indium-based quantum dots
(QDs) as a non-viral gene therapy vector. The QDs were solubilized in water by
exchanging native hydrophobic surface ligands with 11-mercaptoundecanioc acid
(MUA); an amphiphilic ligand providing terminal carboxylate groups that impart water
solubility to the QDs. The aqueous QDs were then functionalized with a terminal tertiary
amine to impart a positive surface charge, allowing negatively-charged DNA to complex
with the nanoparticles. The QDs were characterized via electrophoresis to determine their
ability to bind DNA. Results show that further work is needed to optimize DNA binding.
In addition, this work explores QD bioconjugation with lactose as an intracellular
targeting molecule, to direct QD complexes to the cellular nucleus. Conjugation with
lactose was confirmed via nuclear magnetic resonance (NMR) spectroscopy. QD probes
trafficking in N2a (mouse neuroblastoma) cells was visualized using fluorescence
microscopy and immunocytochemistry (ICC). The images were analyzed via Manders’
coefficient to determine the degree of QD colocalization with different organelles inside
the cell. Results proved inconclusive due to instrumental limitations.
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CHAPTER 1: INTRODUCTION

1.1 Quantum Dots
Quantum Dots (QDs) are small semiconducting nanocrystals ranging in size from
2-20 nanometers (nm) that fluoresce brightly when irradiated with ultraviolet or visible
light1. QDs are typically composed of group II and VI, or group III and V elements2.
There are a number of unique advantages to QDs including their small size, size-tunable
emission wavelength, and increased photostability compared to organic dyes. Current
work with QDs include applications in solar cells, photodetectors, LEDs, medical
diagnostics and therapeutics1,3,34,35. The ability to carefully control surface characteristics
and functionality of QDs makes them an excellent choice for use in biomedical
applications.
When irradiated with UV light, electrons in the QD become excited. The excited
electrons create an exciton pair consisting of an electron and a positive hole. There are
several modes of relaxation the electron can undergo (Figure 1.1). If the electron
recombines with the hole, then a photon is released (i.e. fluorescence). This path is
known radiative relaxation. There are several ways that allow the electron to relax
without emitting a photon, collectively known as non-radiative relaxation. These include
relaxation of vibrational or rotational modes and intersystem crossing. If the electron
undergoes non-radiative relaxation, it can cause the formation of a surface defect, leading
to trap states. Trap states cause a decrease in overall fluorescence and quantum yield of
the QDs. In order to protect the QDs from trap states and surface defects a core/shell
structure is typically employed.
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Currently, the most popular QD core/shell system used is cadmium selenide/zinc
sulfide (CdSe/ZnS). CdSe QDs exhibit intense fluorescence and narrow emission peak
widths39. Their use in biomedical applications does have some concern due the toxicity of
Cd2+ ions that may be released through degradation of the QD40. Other core systems can
be employed to increase biocompatibility of the QDs. In this study, indium-based QDs
were used, specifically indium phosphide/zinc sulfide, because they possess similar
characteristics of cadmium-based QDs without the toxicity of Cd2+ ions41. Indium-based
QDs have lower quantum yield and broader emission peaks, yet are still being used in
biomedical applications despite these characteristics43.

Figure 1.1. Jablonski diagram7. The Jablonski diagram shows different methods of
relaxation for an excited electron.
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The fluorescence property of QDs comes from the size of the QD itself. Typical
indium phosphide (InP) QDs range in size from 2-6 nm4. The fluorescent properties of
QDs come from the fact that they are smaller in size than the exciton Bohr radius. The
exciton Bohr radius is defined as the distance between an excited electron and the hole
left behind after excitation. The result is that the energy levels within the QD become
discrete, quantized levels and no longer exhibit continuous bandgap properties like bulk
semiconductors. Another effect of the QD size is a property known as quantum
confinement in which the band gap of the QDs increase as their physical size decreases5.
Smaller QDs fluoresce toward the blue end of the spectrum while larger QDs are more
red shifted (Figure 1.2). This allows for size-tunable emission wavelengths that can be
tailored to fit the experiment at hand.

Figure 1.2. Size-tunable emission of quantum dots6. The emission wavelength of QDs
depends on the QD size. Quantum confinement allows for discrete energy levels unlike
bulk semiconductors. The size of the QD and its band gap have an inversely proportional
relationship. As the size of the QD increases, the band gap increases resulting in a red
shifted emission wavelength.
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The core of the QD is susceptible to oxidative degradation as well as the surface
defects mentioned above. When exposed to UV light in the presence oxygen, the cores
undergo oxidation8 (Figure 1.3). The oxidation reduces the overall size of the QD and can
be observed as a blue shifting of the emission fluorescence. If the QDs continue to
degrade they will eventual cease to fluoresce. In order to prevent surface oxidation, a
shell is added around the QD core to protect it. Typical shells are composed of zinc and
sulfur, coating the QD core with about 3-6 monolayers of zinc sulfide (ZnS).

Figure 1.38. An example of the process of oxidative degradation of CdSe QD cores.
When exposed to oxygen and UV light, the QD cores can oxidize. Oxidation of the cores
can manifest as a blue shifting in fluorescence emission (due to the size decrease in the
QD size) and/or dimming of the fluorescence intensity.
After synthesis, the QDs have hydrophobic surface ligands, rendering them insoluble
in water. To be useful in many applications (e.g. biomedical applications) the QDs must
to be soluble in water. There are three major methods used to impart water solubility:
which include 1) silica encapsulation, 2) polymer encapsulation, and 3) ligand exchange.
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Each method has advantages and disadvantages in terms of stability, size increase, and
technical effort needed.
Silica encapsulation involves depositing a layer of SiO2 around the QD core.
Typically, silica precursors are added after core growth to encapsulate the QD and leave
the hydrophilic SiO2 on the surface9. The silica coating of the QD not only provides water
solubility but excellent protection of the core including in acidic environments. The
downside to silica encapsulation is the uneven coating of silica around the QDs32.
Variable size distribution pose issues in some applications.
Another method of solubilization is polymer encapsulation. In this method, the
native hydrophobic ligands on the QD surface are used along with an amphiphilic
polymer to impart water solubility. Trioctylphosphine oxide (TOPO) is a hydrophobic
ligand often used in QD synthesis and therefore is often found on the QD surface after
synthesis. Other surface ligands may include long chain amines or thiols such as
oleylamine or dodecanethiol, respectively. The amphiphilic polymer contains both
hydrophobic and hydrophilic moieties. The hydrophobic moieties of the polymer interact
with the native hydrophobic ligands on the QD surface while the hydrophilic moieties are
exposed to the solvent (Figure 1.4). The hydrophilic surface now provides water
solubility for the QDs. The amphiphilic polymer can contain chemical handles such as
carboxyl or amine groups to allow for further modification or bioconjugation of the QD.
The large polymer allows for a lot of interaction between itself and the QD which, in
turn, provides good stability in solution over time. Disadvantages of the polymer
encapsulation method include the increased size of the QDs, and the possibility of
encapsulating multiple QDs together. That is, with the large polymers typically used in
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this reaction, it is possible to wrap multiple QDs together instead of creating single
encapsulated QDs.

Figure 1.4. Water solubilization of QDs via polymer encapsulation. The native ligands on
the QD surface interact with the hydrophobic portion of the amphiphilic polymer in order
to impart water solubility to the QDs. The exposed hydrophilic portion of the polymer
contains various chemical handles the can be used to further modify the QDs.
Another method of water solubilization is ligand exchange. The native
hydrophobic ligands on the QD are datively bonded to the QD surface. In ligand
exchange, amphiphilic ligands are introduced to compete for binding on the QD surface
(Figure 1.5-1.6). Thiols are often used because they bind well to zinc in the QD shell. The
sulfur in the thiol ligands forms a stronger bond than the oxygen of TOPO, causing the
TOPO ligands to be replaced. There are several commonly used thiol ligands including 3mercaptopropanoic acid (MPA), 11-mercaptoundecanoic acid (MUA), and dihydrolipoic
(DHLA). Both MPA and MUA are monovalent ligands, meaning that each ligand has one
6

binding spot. One of the downfalls of ligand exchange is the decreased long term stability
in solutions. The ligands can dissociate from the QDs over time resulting in a loss of
water solubility. It is possible to avoid this effect by using multidentate ligands, such as
DHLA, which has two sulfur atoms. Additionally, some research groups have reported
using tetradentate sulfur ligands to further increase the long-term water solubility of
QDs10. The resulting QDs after ligand exchange a much smaller size than polymerencapsulated QDs. This is key for applications that need the small size of QDs to be
effective. The biggest advantage of ligand exchange over the other techniques is that the
surface chemistry of the QDs can be highly controlled. This leads to more uniform QDs
without variations in size or surface moieties.

QD

QD

Figure 1.5. Water solubilization of QDs via ligand exchange. The native hydrophobic
ligands on the QD surface are exchanged for hydrophilic ligands in a biphasic reaction.
The terminal ends of the new ligands allow for further chemical modification as well as
imparting water solubility. This example shows native oleylamine ligands being
exchanged with MPA.
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Figure 1.6. Ligand exchange phase transfer of QDs27. As the solution stirs, native QD
ligands exchange for hydrophilic ligands in the aqueous layer. Overtime all the QDs
move from the bottom organic layer to the upper aqueous layer.
1.2 Gene Therapy
Gene therapy is a powerful tool that has been used in an attempt to treat many
genetic diseases11,12. Gene therapy uses a delivery vector to deliver therapeutic DNA to
cells to replace missing or mutated genes. Viruses are a common vector in gene therapy
because of their innate ability to deliver DNA into cells. There are also many non-viral
techniques being researched due to the safety concerns of using viral vectors13.
Currently, the most common therapeutic technique is viral gene therapy. Many
types of viruses are used; retroviral vectors are the most common of all viral vectors12. In
order for the virus to safely deliver the therapeutic gene, the genome of the virus is
modified to remove infectious or damaging DNA sequences. Even though viral vectors
are extremely efficient at delivering DNA, there are a number of safety concerns
associated with them. One of the first clinical trials using viral gene therapy was
conducted in 1992 in Italy for the treatment of hereditary diseases. Many years after
treatment, patients began suffering from leukemia, and concerns over the safety of gene
8

therapy were raised11,12. Many viral gene therapy clinical trials were temporarily halted
until safety concerns could be addressed36,37,38. The problem is that even though viral
vectors could deliver the DNA there was no way to control where the DNA was inserted
into the patients genome. Improper insertion of the exogenous DNA could lead to the
disruption of healthy gene expression12. For example, if a gene controlling the cell cycle
was disrupted, the cell could become cancerous.
There are a number of non-viral gene therapy methods that have been explored as
a way to alleviate some safety issues of using viral vectors. Lipoplexes or polyplexes are
materials that are used to deliver therapeutic DNA. These vectors condense and protect
DNA with the respective organic complexing agent. Lipoplexes are cationic lipids that
electrostatically interact with DNA and cause condensation of DNA with the lipid. The
lipid:DNA complex is thought to enter the cell through endocytosis where it must then
diffuse into the cytosol14,15. Polyplexes work in a similar way except they involve using a
positively charged polymer (e.g. polyethylenimine, PEI) to complex the DNA.
Polyplexes tend to be amorphous in shape and polydisperse in size, causing them to be
more difficult to characterize. QDs that are inherently positively charged are a possible
solution to the irregularity of lipoplexes and polyplexes.
Although non-viral vectors are safer than their viral counterparts, there are still
several issues that must be overcome. Non-viral vectors are not nearly as efficient at
delivering DNA to the nucleus of a cell. The most common method of entry into the cell
is through endocytosis16. Two types of endocytosis, clathrin-mediated or caveolinmediated, are believed to be the major ways in which the vectors are internalized. Upon
internalization, the vectors are in vesicles known as endosomes. The exogenous material
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is sorted into specific vesicles, depending on the identity of the material, and then
vesicles are trafficked through different routes in the cell. The least favorable outcome for
therapeutic DNA is trafficking to the lysosomes. Lysosomes have a low pH (e.g. 4-5) and
contain nucleases that will degrade any therapeutic DNA. In order to avoid lysosomal
trafficking of the therapeutic DNA, there needs to be a way to direct the trafficking away
from the lysosomes (e.g. via a targeting molecule). Previous work has shown non-viral
vectors that incorporate sugar molecules may be trafficked toward the Golgi31. This is
promising because the lumen of the ER is contiguous with the space between the inner
and outer nuclear membranes
The use of QDs as a non-viral vector allows for a great variety of surface
modifications to mediate cellular uptake and trafficking. Molecules can be conjugated to
the QDs to act as targeting agents or change the chemistry of the surface (e.g. reducing
surface charge). This work explores the use of lactose as a targeting agent and the
addition of poly(ethylene) glycol (PEG) polymers to increase uptake and reduce nonspecific binding17,18.

1.3 Lactose and Galectin-3
Lectins are carbohydrate-binding proteins found in plants and animals. There are
a number of different lectins in mammalian cells but galectin-3 is of particular interest to
this work. Galectin-3 is a 31 kDa protein that specifically binds β-galactosides19,20 (i.e.
sugars containing galactose). The majority of galectin-3 is located within the cytoplasm
of the cell but some cell types can also express a significant amount within the
nucleus19,21. Galectin-3 had been shown to enter the nucleus of cells via passive diffusion
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as well as active transport33. A six amino acid sequence in the protein acts as a nuclear
localization sequence allowing for active transport through the nuclear pore.
One common β-galactosides is lactose. Lactose is a disaccharide composed of a
glucose and galactose sugar. Galectin-3 exhibits a high affinity for lactose and Nacetyllactosamine19,21. Lactose can be conjugated to the QD through the use of chemical
handles on the QD surface (i.e. carboxylate groups). The alcohol groups of the lactose
can be reacted with the carboxylate groups on the QD surface to form stable ester bonds.
We propose using lactose as a targeting molecule to help deliver QD:DNA conjugates to
galectin-3. The complex may be trafficked toward the nucleus of the cell using native
cellular trafficking.

1.4 Cell Culture
In order to perform the in vitro studies employed in this project, it was necessary
to maintain stable cell lines of mammalian cells. All work with these cells needs to be
performed in a sterile environment to prevent contamination. Equipment and solutions
must be kept sterile; therefore, all cell culture studies were done in a bio-safety cabinet.
An autoclave was used to sterilize all hardware used in cell culture experiments.
Disposables (e.g. cell flasks, pipette tips, etc.) brought into the bio-safety hood were
wiped with a 75% ethanol solution to ensure proper sanitation. Cells were kept in an
incubator at a constant 37 °C to ensure optimal growth. A bicarbonate-buffered media
was used to maintain a constant pH in the cell culture flask; therefore, the incubator also
maintained an atmospheric concentration of CO2 at 5 %. The presence of phenol red in
the cellular media allows quick assessment by color to roughly indicate the pH. It is a
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bright pink color above pH 8.2; red at physiological pH, and orange-yellow as the pH
approaches 6.8. Proper techniques must be used to ensure viability of the cells for use in
cellular studies.
The N2a (mouse neuroblastoma) cell line was used in cellular studies discussed
herein. The cells were grown in cell culture flasks and split every 2-3 days to maintain
healthy growing conditions. If the cells become overly confluent they begin growing on
top of each other instead of in a single monolayer. This may cause differentiation and
changes in cellular morphology, which would complicate the analysis of intracellular
trafficking. In overconfluent cells, selective pressure causes the cells best suited to grow
in unhospitable environments to thrive. The resulting cells no longer represent the model
cell line that was initially chosen. It is important for the cells to retain the characteristics
of the chosen model cell line.

1.5 Microscopy
Microscopy has long been used to study objects which are too small to be seen.
Light microscopy is a specific type in which visible light is used to detect the sample.
There are a number of different types of light microscopies, including phase-contrast
(PC), differential-interference-contrast (DIC), epifluorescence, and confocal microscopy.
Each type has specific uses along with respective advantages and disadvantages.
DIC microscopy is a type of brightfield microscopy used to enhance contrast in
transparent samples such a mammalian cells. In DIC microscopy light first hits a 45°
polarizing lens followed by a Wollaston prism22. This prism causes the polarized light to
separate into two orthogonal rays. The two rays then hit a condenser lens that focuses the
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light onto the sample. The two orthogonal rays will have different optical path lengths
depending on the refractive index of the sample they are passing through. Once the light
leaves the sample it passes through the objective lens and a second Wollaston prism. This
causes the two orthogonal rays of light to recombine. The recombination of light causes
interference, either constructive or destructive, that brightens or darkens parts of the
image. Figure 1.7 shows the complete optical path used in DIC microscopy.
Epifluorescence microscopes are similar to compound microscopes but includes a
fluorescence light source (e.g. mercury arc lamp) and a set of filter cubes. The filter cubes
are composed of an excitation filter, dichroic mirror, and emission filter (Figure 1.8). The
excitation filter only allows a narrow range of wavelengths through that correspond with
the excitation wavelength of the fluorophore. Once passed through the excitation filter
the light is reflected off a dichroic mirror towards the sample. A dichroic mirror reflects
light under a certain wavelength and allows wavelengths above the cutoff to go through.

Figure 1.7. Light path in DIC microscopy23. This image shows the light path during DIC
microscopy. Unpolarized light first hits a polarizing lens resulting in 45° polarized light.
The light then hits a Wollaston prism separating it into two orthogonal rays. A condenser
lens focuses the light through the sample. An objective lens focuses the light coming
through the sample onto a second Wollaston prism which leads to a final polarizing lens.
13

This light is then directed towards and irradiates the sample on the microscope stage and
excites electrons of the fluorophores in the sample. The emitted light from the
fluorophore that is directed towards the objective travels back towards the dichroic mirror
and through an emission filter that removes any stray light. Each fluorophore that is
visualized needs its own set of filters. This allows many different fluorophores to be
visualized in one sample without overlap.
Confocal microscopy is a powerful tool that is often used to study biological
samples, such as cells. The light source used in confocal microscopy is a laser. Laser light
has a very narrow wavelength bandwidth, making it excellent for exciting specific
fluorophores. In normal fluorescence microscopy, the sample is irradiated with light
evenly throughout. Confocal microscopy makes use of two spatial pinholes that block out
of focus light (Figure 1.9). The result is that the only light detected originates from one

Figure 1.8. Filter cube for fluorescent microscopes24. This figure shows the light path
through a filter cube. An excitation filter only allows the specified wavelength through. A
dichroic mirror directs light toward the sample. Light emitted from the sample travels
through the dichroic mirror and through an emission filter to the objective.
14

focal plane of the sample. A stage controller can be used to make very small focal plane
“steps” up through the cell at increments as low as 400 nm and record many image
planes, which collectively are known as a z-stack of the sample. These images can be
processed to create a 3D image of the sample (Figure 1.10).
In order to determine if two different signals come from the same location in the
sample co-localization analysis must be done. A number of different analyses have been
developed to determine the co-localization between the signal detected for two different
fluorophores in a sample.26 (e.g. Pearson’s correlation coefficient and Manders’ overlap
coefficient). There are advantages and drawbacks of each technique; therefore, it is
critical to choose one best suited to the sample and the analysis performed. For this work,
Manders’ co-localization coefficient (MCC) was used to determine the degree of overlap
between the signals detected between the QDs and an organelle fluorescently labeled in
the cell. The overlap between two fluorophores (e.g. red and green) can be expressed as
two different equations in MCC analysis:
𝑀1 =

∑ 𝑅𝑖,𝑐𝑜𝑙𝑜𝑐
∑ 𝑅𝑖

𝑀2 =

∑ 𝐺𝑖,𝑐𝑜𝑙𝑜𝑐
∑ 𝐺𝑖

M1 denotes the fraction of red (R) pixels that overlap with green pixels, while M2
denotes the fraction of green (G) pixels that overlap with red pixels26. In this study, QDs
fluoresce red and cellular organelles of interest were labeled green. For this reason,
analysis herein uses M1 to indicate the overlap of QDs with the organelle of interest. That
is, QD-containing pixels that overlap with organelle-labeled pixels is the objective of the
colocalization analysis, not the overlap of organelle-labeled pixels that overlap with QD
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pixels (i.e. we are most interested in the presence and location of QDs, not the presence
and location of organelles).

Figure 1.9. Light path comparison of conventional and confocal microscopy44. (A)
Conventional microscopy allows light from different planes to be visualized at once. (B)
Confocal microscopy makes use of two pinholes that block all background light. Only
light from the plane being observed passes through to the detector. This allows for many
planes to be imaged and formed into a 3D image.

Figure 1.10. Z-Stacking25. Using confocal microscopy it is possible to take images of a
number of different planes in the sample. Software can be used to merge the image (zstacks) into a 3D image of the sample.
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CHAPTER 2: EXPERIMENTAL

2.1 Chemical List
All chemicals were purchased from Sigma-Aldrich and used as is unless specified
otherwise. Agarose (MidSci, Cat. No. Be-A125), 3-(dimethylamino)-1-propylamine (Cat.
No. D158003), 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methylmorpholinium chloride
(DMTMM) (Cat. No. 749613), hexanes (EMD Millipore, Cat. No. 110-54-3), 3-(Nmorpholino) propanesulfonic acid (MOPS) (Fisher, Cat. No. BP308-500),
paraformaldehyde (PFA) (Cat. No. 158127), poly(ethylene glycol) derivatives ((Creative
PEGworks, H2N-PEG2000-CH3 (“mPEG”) (Cat. No. PLS-269), H2N-PEG2000-COOH
(“cPEG”) (Cat. No. PLS-930)), Triton X-100 (Astoria Pacific, Cat. No. 90-0770-04),
boric acid (Cat. No. B7901), sodium tetraborate decahydrate (Cat. No. S9640), 11mercaptoundecanoic acid (MUA) (Cat. No. 450561 and Chem Cruz, Cat. No. sc251618), tetramethyl ammonium hydroxide (TMAH) (Acros, Cat. No. 207520250),
acetone (Fisher, A1320), Toluene (Fisher, T324), ethanol (Ultra Pure, Cat. No. 16A4E),
20K MWCO dialysis units (Fisher, Cat. No. 69590).
For cell culture and subsequent immunocytochemistry, the following reagents
were used. Dulbecco’s-Modified Eagle’s medium (D-MEM) (Thermo Scientific, Cat. No.
SH30022.01), Opti-MEM reduced serum medium (Life Technologies, Cat. No. 51985034), rabbit anti-giantin antibody (Golgi Apparatus Marker, Abcam, Cat. no. ab24586),
rabbit anti-lamin antibody (Nuclear envelope marker, Abcam, Cat. No. ab16048), rabbit
anti-GRP78 BiP antibody (Endoplasmic reticulum marker, Abcam, Cat. No. ab21685),
rabbit anti-Rab5 antibody (Endosome marker, cell signaling tech., Cat. No. 35478), rabbit
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anti-lamp1 antibody (Lysosome marker, Abcam, Cat. No. ab24170), anti-rabbit Alexa488
conjugated antibody (Life Technologies, Cat. No. A21441), fetal bovine serum (Hyclone,
Cat. No. SH30396.02) antibiotic/antimitotic solution 100X (Penicillin G, Streptomycin,
and Amphotericin B) (Hyclone, Cat. No. SV30079.01), trypsin (Hyclone, Cat. No.
AV30031.01), trypan blue (Hyclone, Cat. No. AV30084.01) and SYBR® Safe (Life
Technologies, Cat. No. S-33102), 12 well plate (Corning, Cat. No. 353043), 18mm
coverslips (Fisher, Cat. No. 12-545-84), N2a (mouse neuroblastoma) cells were a kind
gift provided by Dr. Tania Q. Vu at Oregon Health and Science University.

2.2 Water Solubilization of QDs
After synthesis, QDs are only soluble in organic solvents (e.g. hexanes). To be
useful in biological applications the QDs need to be soluble in water. There are several
different approaches that can be used, as previously discussed in Chapter 1.1. Studies
herein used ligand exchange to impart water solubility on the QDs.
Early attempts at water solubilization were conducted using dihydrolipoic acid
(DHLA) as the solubilizing ligand. Lipoic acid had to be reduced to DHLA before being
useful for water solubilization. Lipoic acid (1 g) was dissolved in 0.25 M sodium
bicarbonate buffer. Slowly, 1.1 molar equivalent of sodium tetraborohydride was added
and allowed to react for 1 hour. The solution was then acidified with 1 M HCl and the
DHLA was extracted using chloroform. The chloroform was removed via rotovap leaving
DHLA. Before beginning, the QDs were washed to remove any excess hydrophobic
ligands in solution after synthesis. For washing, 1 mL of acetone was added to
approximately 500 µL of 7 µM QDs (obtained from Matt Ellis, notebook number MAE-
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001-45) in a 1.5 mL Eppendorf tube. The solution is then spun in a centrifuge at 5000 x g
for 5-10 minutes, causing precipitated QDs to form a pellet at the bottom of the tube. The
supernatant was discarded and the pellet was dissolved in 500 µL of chloroform or
hexanes. This washing process was repeated for a total of three times with the last step
being to not dissolve the QDs (left as a pellet in the tube). Next, 500 µL of DHLA and
500 µL of ethanol was added to the tube containing the pellet of QDs. A small stir bar
was added and the solution was stirred at 60 °C in a water bath for 6-8 hours. After this
reaction period, the solution was moved to a 15 mL Falcon tube. 4.1 mL of an
ethanol/hexane/chloroform (2 mL ethanol, 2 mL hexane, 0.1 mL CHCl3) mixture was
added to the Falcon tube. Hexane was slowly added until the solution became turbid (2-3
mL). The turbid solution was then centrifuged for 15 minutes at 3000 x g. The
supernatant was discarded and the QD pellet was dissolved in 250 µL of water. A 50K
MWCO centrifugal filter was used to further purify the QDs before determining the
concentration as discussed later.
A study published in ACS Nano27 provided a possibly easier method to impart
water solubility on the QDs. The QDs suspended in organic solvent was simply mixed
with amphiphilic ligands in an aqueous solution, with TMAH to aid in the phase transfer
between organic and aqueous phases. The biphasic solution was rapidly stirred forming
an emulsion. As the native hydrophobic ligands exchanged for hydrophilic ligands the
QDs move from the organic layer to the aqueous layer. The method discussed earlier,
using DHLA, was eventually replaced in favor of this simpler method.
11-mercaptoundecanoic acid (MUA) was chosen as the solubilizing ligand for this
experiment due its availability and ease of use. As before the QDs were thoroughly
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washed prior to use using the acetone precipitation method described above. The final
wash step was to dissolve the QD pellet in CHCl3. A 0.5 M solution of
tetramethylammonium hydroxide (TMAH) was made by dissolving 0.453 g of TMAH in
5 mL of DI water. A 0.2 M solution of MUA was made by dissolving 0.218 g of MUA in
the 0.5 M TMAH solution. The MUA was dissolved in the basic TMAH solution to
deprotonate the thiol and allow better binding to the QD surface1. Equal volumes of QDs
and 0.2 M MUA were added together and vigorously stirred for 12-24 hours. Volumes
anywhere from 0.5 mL to 5 mL have been successfully solubilized using this method.
After stirring, the QDs moved from the lower organic layer into the aqueous layer on top
as seen in Figure 1.6. The bottom organic layer was discarded and the aqueous layer then
contained the QDs. The pH of the QD solution was lowered to ~8 using 0.1 M HCl,
checked via pH paper. The QDs were then placed at 4 °C overnight to allow any excess
MUA to precipitate out of solution. After refrigeration, the QDs were spun at 1000x g for
5 minutes to pellet any precipitated MUA. The QD supernatant was collected and the
MUA pellet was discarded. To purify the QD solution, it was dialyzed using a 20k
MWCO dialysis membrane against 0.1 M borate buffer (pH 8.3) for 12-24 hours with
frequent dialysate changes. After purification, the concentration of the QDs was
determined by UV/Vis spectrometry using the method described by Xie et. al.42.

2.3 PEGylation of QDs
After water-solubilization, the surface of QDs were covered with carboxylate
terminal groups from MUA surface ligands. To increase cellular uptake and reduce nonspecific binding, the QDs were conjugated with poly(ethylene glycol) (PEG). Two
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different PEG derivatives were conjugated to the QDs: amine-PEG-COOH (“cPEG”) and
amine-PEG-methoxy (“mPEG”) (Figure 2.1). Primary amine terminal ends of the PEG
can react with carboxylate groups on the QD surface (via MUA) to form stable amide
bonds. The carboxylate terminal of the cPEG is then available for further conjugation.
The methoxy terminal of the mPEG reduces the surface charge of the QD. The ratio of
mPEG to cPEG can be varied to produce QDs with surface charges dependent on the
intended application of the QDs. For this experiment a ratio of 1 cPEG to 5 mPEG was
used. An activator (i.e. DMTMM) was used to allow the reaction between the terminal
carboxylate groups from the QD and amine groups from the PEGs in mild aqueous
conditions. Figure 2.2 shows the mechanism of DMTMM activation. The reaction of
DMTMM with the QDs leaves an excellent leaving group on the QD to allow for reaction
with a primary amine.

Figure 2.1. Chemical Structure of PEG derivatives. (A) amine-PEG-COOH “cPEG”. (B)
amine-PEG-methoxy “mPEG”.
First, 1 mg/mL solutions of DMTMM, cPEG, and mPEG are prepared by
weighing 1 mg of each chemical and dissolving in 1 mL of 0.1 M borate buffer, pH 8.5.
Next, the DMTMM solution was added (at a 5,000 molar excess of QDs) to an Eppendorf
containing water soluble QDs. The DMTMM and QDs were allowed to react for 15
minutes and then transferred to a 20k MWCO dialysis unit. The solution was dialyzed
against 4 L of 0.1 M borate buffer for 15 minutes to remove any unreacted DMTMM.
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This step was necessary to avoid the PEG derivatives from undergoing an intramolecular
reaction. After dialysis, the activated QD solution was placed in an Eppendorf tube and
solutions of mPEG and cPEG are added. The mPEG was added at a 5,000 molar excess
and the cPEG is added at a 1,000 molar excess, respective to the QDs. The solution was
stirred and allowed to react for 3-4 hours. Afterwards, the QDs are dialyzed again against
0.05 M borate buffer overnight to remove any excess PEGs. To ensure an accurate
concentration after dialysis, the QDs were placed in a vacufuge and concentrated back to
the original starting volume. Gel electrophoresis was used to determine success of the
PEGylation. A 0.4% agarose gel was prepared by dissolving agarose in 0.1M borate
buffer and heating until boiling. The QD-PEG conjugates and the QD precursor were
electrophoresed for 30 minutes at 140 V.

Figure 2.2. DMTMM activation mechanism28. Figure shows the mechanism by which
DMTMM activates carboxylate groups. The activated group, shown as “active ester” is
reactive toward amines in mild aqueous conditions.
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2.4 Bioconjugation with Lactose
It is necessary to conjugate a targeting molecule to the QDs to direct trafficking
within the cell to the desired organelle (nucleus). Once more, DMTMM was used to
couple PEGylated QDs to lactose. The intended result of the reaction was a stable ester
bond between terminal carboxylate groups of the PEGylated QDs and a hydroxyl group
from lactose (Figure 2.3).

Figure 2.3. Bioconjugation of PEGylated QDs to Lactose. A. The PEGylated QDs are
first activated with DMTMM to produce reactive intermediates. B. Lactose is then added
and a hydroxyl group of lactose reacts with the PEGylated QDs to produce a stable ester
bond. There are eight hydroxyl groups on lactose; while it is theorized primary alcohols
are more reactive, it is unknown which hydroxyl reacts with the QD.
A 1 mg/mL solution of DMTMM was used to activate the carboxylate groups of
the PEGylated QDs. The DMTMM was added at 5,000 molar excess to a solution of 500
nM PEGylated QDs in an Eppendorf tube and allowed to react for 15 minutes. A 5
mg/mL solution was lactose is prepared in 0.1 M borate buffer, pH 8.5, and added at
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5000 molar excess with respect to the QDs. The solution was stirred and allowed to react
for 4-6 hours. After the reaction was complete the solution was dialyzed in a 20k MWCO
dialysis unit against 0.05 M borate buffer overnight. A vacufuge was used to concentrate
the solution back to the original volume of QDs to identify QD concentration. The
success of the reaction was confirmed by nuclear magnetic resonance (NMR)
spectroscopy.

2.5 Imparting Positive Charge
For the QDs to able to electrostatically bind DNA they must have a positive
surface charge. After water solubilization the QDs was passivated with MUA; the QD
surface was negative due to the terminal carboxylate groups of MUA. Therefore, the QDs
must be functionalized in a way that imparts a positive surface charge while still
maintaining water solubility. The carboxylate groups on the QD surface were reacted
with the diamine compound 3-(dimethylamino)-1-propylamine (DMAPA). DMAPA
contains both a terminal primary amine which can be reacted with carboxylates and a
terminal tertiary amine that remains unreactive under the reaction conditions. Figure 2.4
shows the reaction scheme used. As with the other reactions, DMTMM was first used to
activate carboxylate groups (via MUA) on the QD surface. A 10,000 molar excess of
DMTMM (relative to the QDs) was added to a 1.5 mL centrifuge tube containing 500 nM
water-soluble QDs in 0.1M borate buffer, pH 8.5, and allowed to react for 15 minutes.
Then, a 10,000 molar excess of DMAPA (relative to QDs), diluted to ~0.01M in 0.1M
borate buffer, was added to the tube containing the QDs. The reaction was stirred for 4-6
hours and then dialyzed in a 20k MWCO dialysis unit overnight against 0.05M borate
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buffer, pH 8.5. After dialysis, a vacufuge was used to concentrate the QD solution back
to the starting volume. Once completed, the success of the reaction was investigated
using gel electrophoresis.
Gel electrophoresis was used to determine the successful addition of DMAPA to
the QD and the ability of the QD:tert-amine conjugates to electrostatically bind
polyanionic DNA. The QD:tert-amine conjugates were electrophoresed through a 0.4%
agarose gel containing SYBR Safe (a green fluorescing DNA dye) in 0.1M MOPS buffer
(pH 7.0). The QD conjugates were incubated with pDNA (4 µL QDs to 2 µg pDNA) at
room temperature for 10 minutes before loading into the gel. The samples were
electrophoresed for 30 minutes at 120V and then visualized with a UV transilluminator.

Figure 2.4. Scheme depicting the reaction of QDs with a diamine. A. The QDs were first
activated with DMTMM. B. DMAPA was added and reacted with the activated
carboxylate groups. The resulting reaction functionalized the surface of the QD with
tertiary amines which are protonatable at physiological pH.
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2.6 Immunocytochemistry and Microscopy
A model cell line of N2a cells (Mouse Neuroblastoma, ATCC Cat #HB-12317)
were used to visualize the cellular trafficking of the QD-PEG-lactose conjugates. Cells
were grown in media consisting of Dulbecco’s Modified Eagle’s Medium (DMEM)
supplemented with 10% fetal bovine serum (FBS) along with antibiotic and antimitotic
solution (100 units/mL Penicillin G, 100 µg/mL Streptomycin, and 0.25 µg/mL
Amphotericin B). Cells were cultured and passaged every 2-3 days to prevent
overcrowding within the cell culture flask.
N2a cells were plated onto 18 mm circular coverslips in a 12 well plate at a
density of 40,000 cells/well and allowed to incubate for 24 hours at 37 °C in a 5% CO2
incubator. When cells reached ~60% confluency, they were incubated with the
lactosylated QDs. The lactosylated QDs were diluted in cell culture media to a final
concentration of 8 nM. At this time, spent media in each well was aspirated away,
replaced with media containing lactosylated QDs, and incubated at 37 °C for 8 hours.
The cells were then fixed using 4% paraformaldehyde (PFA) in phosphate buffered saline
(PBS) for 15 minutes. After fixing, the cells were permeabilized with 0.5% Triton X-100
for 20 minutes and then washed three times with PBS for 10 minutes. At this point, cells
could be stored at 4 °C indefinitely as long as PBS did not evaporate to dry the
coverslips.
Immunocytochemistry (ICC) was used to label and visualize cellular proteins
using antibodies. Cellular organelles were labeled using antibodies specific for proteins
that localize within that particular organelle. To visualize where lactosylated QDs
localized within the cell, a variety of organelles were labeled. In this study, the organelles
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labeled were nuclear envelope, Golgi body, endoplasmic reticulum (ER), lysosomes, and
early endosomes (EE).
First, fixed and permeabilized cells containing lactosylated QDs were blocked
with 10% bovine albumin serum (BSA) in PBS for 1 hour. Cells were then incubated
with primary antibodies at the concentration recommended by the manufacture in
humidified chambers overnight at 4 °C. The following day, cells were washed three times
with PBS for 15 minutes and then blocked again for 1 hour with 10% BSA in PBS. The
coverslips were then incubated with the secondary antibody, anti-rabbit Alexa488 (11000 dilution in 10% BSA in PBS), for 1 hour at room temperature. Following secondary
incubation, cells were washed three times with PBS for 15 minutes and then stored in the
12 well plate with 0.1 M borate buffer, pH 8.5. The coverslips could then be placed into a
magnetic imaging chamber for use in fluorescence microscopy.
Both epifluorescence and confocal microscopy were used to visualize QD
conjugates with the cells. For epifluorescence microscopy, a Zeiss Axio Observer
microscope equipped with a Zeiss Axiocam MRm CCD camera was used. Two sets of
filter cubes were used during imaging: Rhodamine (ex545nm/em605nm) and FITC
(ex470nm/em525nm) (Figure 2.5). The sets of filters in each cube allowed for
visualization of each fluorophore individually (i.e. Alexa488 and QDs). Figure 2.6 shows
the excitation/emission spectra for each fluorophore. The FITC filter cube was used to for
visualizing the Alexa488-conjugated antibodies used for ICC. The rhodamine cube was
used for visualizing the QD conjugates.
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Figure 2.5. Filter cube emission and excitation cutoffs. Two filter cubes were used to
visualize the cells during microscopy. (A) FITC cube – used to visualize Alexa488
conjugated antibodies. (B) Rhodamine cube – used to visualize QD conjugates.

Figure 2.6. Excitation and emission of Alexa488 and QD conjugates29. These spectra
show the excitation (dotted lines) and emission (solid lines) spectra of each fluorophore.
The filter cubes used were chosen to remove any overlap between signals.
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CHAPTER 3: RESULTS AND CONCLUSIONS

3.1 Water Solubilization of QDs
Early attempts at imparting water solubility to the QDs were done using
dihydrolipoic acid (DHLA). The use of a bidentate ligand, in theory, should provide more
stable water-soluble QDs due to the two binding sites with the QD surface. However,
many trials resulted in only partial solubilization of the QDs. Some QDs became watersoluble while others remained soluble only in organic solvents, or precipitated out of
solution all together. The likely cause of this incomplete transfer of QDs from organic
solvent to aqueous buffer is due to oxidation of the DHLA. The two sulfhydryl groups of
DHLA can be oxidized to form an intramolecular disulfide bond, resulting in the
formation of lipoic acid. Lipoic acid cannot bind to the QD surface because it now lacks
the sulfhydryl groups required to bind to the QD surface. The work up after solubilization
was also tedious and not optimized. Different organic solvents (i.e. CHCl3, hexanes, and
ethanol) had to be added in precise amounts to cause turbidity in the sample. This method
of water solubilization left a lot of room for error that resulted in incomplete
solubilization of the QDs.
After solubilization trials with DHLA, 11-mercaptoundecanoic acid (MUA) was
chosen as the solubilizing ligand. The MUA solubilization protocol was a simpler, more
repeatable method. A solution of MUA was added to the QDs in organic solvent and
stirred resulting in complete solubilization of the QDs (Figure 3.1). The concentration of
MUA was optimized and 0.2 M MUA was found to work best. Less MUA resulted in
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incomplete solubilization of the QDs while more resulted in excess MUA that proved
difficult to remove.

Figure 3.1. Water solubilization of QDs. These images show the successful transfer of
QDs from chloroform (left image) to an aqueous solution (right image).
Once the QDs were soluble in water, some purification needed to be done to
remove excess MUA from solution. After solubilization, the QD solution has a pH of
~11. Adding 0.1 M HCl to lower the pH to ~8 resulted in MUA precipitating out of
solution. Unbound MUA is not very soluble in a solution below pH 10. The QDs were
then placed in a refrigerator at 4 °C for several hours, allowing more MUA to precipitate
from solution. Finally, dialysis overnight was used to remove any MUA left in solution.
QDs successfully solubilized by either MUA or DHLA proved to be stable in
aqueous solution. Samples of MUA-solubilized QDs were stable for several months
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stored at 4 °C in 0.1M borate buffer. DHLA-solubilized QDs stored at room temperature
in 0.1 M borate buffer have been stable for over a year.
Previous work in our lab was used polymer encapsulated QDs. A benefit to using
a ligand exchange solubilization (vs. polymer encapsulation) is a decrease in overall size.
Dynamic light scattering (DLS) was used to determine the hydrodynamic radius of the
water-soluble QDs. Figure 3.2 demonstrates that QDs solubilized by ligand exchange are
approximately 4 nm smaller in diameter. Solubilization via ligand exchange also
produced QDs that were more uniform in size (evidenced by a lower standard deviation
in hydrodynamic diameter, Figure 3.2).

Figure 3.2. DLS size comparison between solubilization methods30. Solubilization via
ligand exchange method produces smaller, more uniformly sized QDs as compared to
polymer encapsulation.
3.2 Surface Functionalization of Water Soluble QDs
After the InP/ZnS QDs were soluble in water, the terminal carboxylate groups
(via MUA) were functionalized to reduce non-specific binding and target the QD within
the cell. To reduce non-specific binding both mPEG and cPEG (Figure 2.1) were
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conjugated to the QDs. Addition of poly(ethylene glycol) was shown in previous work to
reduce non-specific cellular interactions with the QDs17,18. The addition of PEG was
accomplished using DMTMM as an activator, and successful PEGylation was confirmed
via agarose gel electrophoresis (Figure 3.3). PEGylated QDs are larger and have a
reduced surface charge due to terminal methoxy groups of mPEG; therefore, PEGylated
QDs to not move as far through the gel as unconjugated QDs.

Figure 3.3. Electrophoretic characterization of PEGylated QDs. An agarose gel was used
to confirm conjugation of PEG to the QDs. Lane 4 shows the PEGylated QDs and lane 5
shows unconjugated QDs. The PEGylated QDs move slower through the gel due to
increased size and decreased surface charge.
Once the PEGylated QDs were confirmed via electrophoretic characterization,
lactose was conjugated to terminal carboxylate groups of the QD. DMTMM was used as
an activator to conjugate lactose to the QDs. Hydrogen NMR was used to confirm
successful conjugation between lactose and the QDs. The peaks of the hydrogens on the
anomeric carbons of lactose were used to determine successful conjugation. These peaks
appear as doublets at 4.31-4.33 and 5.08-5.09 ppm, respectively (Figure 3.4). The
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presence of these peaks in the NMR spectrum of the QD-lactose conjugate confirms
lactosylation of PEGylated QDs (Figure 3.5).

Figure 3.4. 1H NMR of lactose at 400 MHz in D2O. Peaks labeled A and B represent the
hydrogens on the anomeric carbons of lactose.

Figure 3.5. 1H NMR of QD-lactose conjugates at 400 MHz in D2O. Peaks labeled A and
B depict the anomeric hydrogens of lactose, demonstrating successful conjugation of
lactose to the QDs.
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3.3 Imparting Positive Charge
To electrostatically interact with pDNA, the QDs must have a positive surface
charge. A diamine compound, 3-(dimethylamino)-1-propylamine (DMAPA), was chosen
because of its small size and presence of both primary and tertiary amino groups. The
primary amine was reacted with the terminal carboxylate groups on the QD surface using
DMTMM as an activator. The tertiary amine is not reactive under these conditions and is
protonatable at physiological pH (~7.4), serving as a source of positive charge on the
QDs. Gel electrophoresis was used to investigate the surface charge of the QD-diamine
conjugates (here on referred to as “QD-tert-amine conjugates”). The addition of DMAPA
to the QD surface was expected to impart positive surface charge on the QDs.
Unconjugated QDs migrated toward the positive electrode, as expected; however, QDtert-amine conjugates appeared to remain in the well (Figure 3.6). There are two possible
explanations for the QD-tert-amine not migrating within the gel: 1) The QD-tert-amine
conjugates aggregated to the degree that they are too large to move through the gel
matrix, or 2) the QD-tert-amine have a neutral surface charge and therefore do not
migrate toward either electrode. To test the second hypothesis, the molar ratio of
DMTMM was increased in an attempt to activate additional carboxylate groups on the
QD surface. In theory, if more carboxylate groups are activated, this may allow more
DMAPA to react, further increasing the positive charge on the QD surface. However, this
increase in the molar ratio of DMTMM caused the QDs to precipitate out of solution
during the reaction. It is believed that upon activation of too many terminal carboxylate
groups the QDs lose water solubility and precipitate from solution. This doesn’t allow
any further reaction to take place.
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Figure 3.6. Electrophoretic characterization of QD-tert-amine conjugates. Lane 1 –
Precursor (control) QDs. Lane 2 – Empty. Lane 3 – QD-tert-amine conjugates. This gel
shows that the control QDs moved toward the positive electrode as expected. However,
the QD-tert-amine conjugates remained in the well, and did not migrate toward either
electrode.
Electrophoresis was used to investigate any electrostatic interaction between the
QD-tert-amine conjugates and plasmid DNA (pDNA). The QD-tert-amine conjugates
were incubated with pDNA for 10 minutes at room temperature and then loaded into the
gel. SYBR Safe, a green fluorescent dye that intercalates DNA, was added to the agarose
gel to allow visualization of the pDNA.
As expected, unconjugated QDs moved toward the positive electrode due to the
negative surface charge imparted by MUA. (Figure 3.7, lane 1). Much of the QD-tertamine conjugates, which were not incubated with pDNA, was retained in the well (lane
2); however, a small amount of QD-tert-amine conjugates appear as a faint streak toward
the positive electrode, indicating at least a partial negative surface charge. In lane 3, QDtert-amine conjugates incubated with pDNA, did appear to migrate from the well as well.
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However, the pDNA added to the QD-tert-amine sample appears to have migrated
independently of the QD-tert-amine, i.e. similar to the migration of pDNA alone (lane 4).
The independent migration patterns in lane 3 do not indicate an interaction between the
pDNA and QDs (Figure 3.7). These results seem to indicate that the surface charge of the
QD is partially negatively charged and therefore is not able to electrostatically complex
the pDNA.

.
Figure 3.7. Interaction of QD-tert-amine and pDNA. Lane 1 – Unconjugated QDs. Lane
2 – QD-tert-amine. Lane 3 – pDNA and QD-tert-amine. Lane 4 – pDNA control. The
QD-tert-amine and pDNA were allowed to incubate at room temperature for 10 minutes
prior to loading into the gel. Lane 3 shows that the pDNA appears to not interact with the
QD-tert-amine conjugates and migrate independently through the gel.
Attempts to increase the positive surface charge of QDs by increasing the molar
ratio of DMTMM in the DMAPA reaction proved unsuccessful. The increase in
DMTMM caused the QDs to precipitate from solution. This may be due to the conversion
of too many carboxylate groups into the active ester intermediate during the reaction. The
carboxylate groups aid the solubilization of QDs in water due to the presence of the
negatively charged carboxylate groups. The activated ester (Figure 2.2) does not contain
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any charged groups and may decrease water solubility causing the aforementioned
precipitation of QDs during the reaction.

3.4 Cellular Trafficking of QD-Lactose Probes
To visualize trafficking of the lactosylated QDs, cells were imaged using
fluorescence microscopy after performing ICC. The organelles labeled during ICC were:
the Golgi apparatus, the nuclear envelope, lysosomes, and early endosomes. Control
coverslips were also imaged that were treated with unconjugated QDs. Both
epifluorescence and confocal microscopy were used to visualize the trafficking of QDs in
the cells.
Epifluorescence microscopy was used initially to visualize cellular trafficking of
the lactosylated QDs. Figures 3.8 and 3.9 show cells treated with QDs and
immunolabeled for the Golgi apparatus. There appears to be some overlap between the
QDs and Golgi in both cases. However, it is not possible to draw a conclusion on whether
the two colocalize or not using epifluorescence microscopy. The QDs could be
colocalized with the Golgi, or the QDs could be localized above or below the Golgi, due
to the large width of the focal plane in epifluorescence microscopy. Figures 3.10 and 3.11
depict cells immunolabeled for the nuclear envelope, and Figures 3.12 and 3.13 depict
cells immunolabeled for the lysosomes. Similar to cells with labeled Golgi apparatus,
there appears to be some overlap between the labeled organelle and the QDs. To
quantitatively analyze colocalization, the cells must be imaged using confocal
microscopy. Confocal microscopy can be used to visualize very thin focal planes within
the cells to determine colocalization.
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Figure 3.8. N2a cells incubated with unconjugated QDs and immunolabeled for the Golgi
apparatus. These images show N2a cells incubated with 6 nM unconjugated QDs for 8
hours and immunolabeled for the Golgi apparatus. (A) DIC image of N2a cells. (B) the
Golgi apparatus. (C) QDs. (D) Overlay of Golgi and QDs (E) Overlay of images A-C.
Bar = 10 m.
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Figure 3.9. N2a cells incubated with lactosylated QDs and immunolabeled for the Golgi
apparatus. These images show N2a cells incubated with 6 nM lactosylated QDs for 8
hours and immunolabeled for the Golgi. (A) DIC image of N2a cells. (B) Golgi
apparatus. (C) Lactosylated QDs. (D) Overlay of Golgi and QDs. (E) Overlay of images
A-C. Bar = 10 µm.
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Figure 3.10. N2a cells incubated with unconjugated QDs and immunolabeled for the
nuclear envelope. These images show N2a cells incubated with 6 nM unconjugated QDs
for 8 hours and immunolabeled for the nuclear envelope. (A) DIC image of N2a cells. (B)
Nuclear envelope. (C) QDs. (D) Overlay of nuclear envelope and QDs. (E) Overlay of
images A-C. Bar = 10 µm.
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Figure 3.11. N2a cells incubated with lactosylated QDs and immunolabeled for the
nuclear envelope. These images show N2a cells incubated with 6 nM lactosylated QDs
for 8 hours and immunolabeled for the nuclear envelope. (A) DIC image of N2a cells. (B)
FITC channel showing the nucleus. (C) Lactosylated QDs. (D) Overlay nuclear envelope
and QDs. (E) Overlay of images A-C. Bar = 10 µm.
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Figure 3.12. N2a cells incubated with unconjugated QDs and immunolabeled for the
lysosomes. These images show N2a cells incubated with 6 nM unconjugated QDs for 8
hours and immunolabeled for the lysosomes. (A) DIC image of N2a cells. (B)
Lysosomes. (C) QDs. (D) Overlay of lysosomes and QDs. (E) Overlay of images A-C.
Bar = 10 µm.
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Figure 3.13. N2a cells incubated with lactosylated QDs and immunolabeled for the
lysosomes. These images show N2a cells incubated with 6 nM lactosylated QDs for 8
hours and immunolabeled for the lysosomes. (A) DIC image of N2a cells. (B)
Lysosomes. (C) Lactosylated QDs. (D) Overlay of lysosomes and QDs. (E) Overlay of
images A-C. Bar = 10 µm.
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In a second imaging experiment, ICC was used to label different cellular
organelles, confocal microscopy was used to visualize trafficking of QDs within the cell,
and Manders’ colocalization coefficients were used to determine the overlap between the
red channel (QDs) and green channel (organelles). The M1 value was examined instead
of M2 because M1 focuses on red pixels (QDs) while M2 focuses on green pixels
(organelle). However, upon examination of the figures, significant bleed-through from
the green channel into the red channel was observed. That is, some of the signal in the red
channel originated from the green fluorophore, distorting the results. Because of this
bleed-through, it was not possible to accurately calculate the amount of co-localization.
However, the Manders’ coefficient still might hold some useful information if the amount
of bleed-through was consistent for each image. If so, comparison of M1 values between
cells incubated with unconjugated QDs and lactosylated QDs may indicate if the
presences of lactose caused any change in QD trafficking within the cell.
A z-stack of images can be visualized by creating a what is known as a maximum
projection. In generating a maximum projection, each pixel in the stack is analyzed and
the pixel with the highest intensity is chosen to create the final image. Maximum
projections were created (Figures 3.14 – 3.19) for each imaged cell with internalized
QDs. While the maximum projection is shown here for visual purposes, the quantitative
analyses described below used the entire 3-D volume of the cell (i.e. each slice in each
stack was included in the analysis).
Manders’ co-localization analysis was performed on three confocal z-stacks to
calculate an M1 value. M1 values for co-localization between the QDs and the Golgi
apparatus were 0.502 ± 0.009 for unconjugated QDs and 0.521 ± 0.237 for lactosylated
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Figure 3.14. 3-D maximum project image used to investigate colocalization between the
Golgi apparatus and lactosylated QDs. Green: Golgi apparatus, Red: lactosylated QDs.

Figure 3.15. 3-D maximum project image used to investigate colocalization between the
Golgi apparatus and unconjugated QDs. Green: Golgi apparatus, Red: lactosylated QDs
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Figure 3.16. 3-D maximum project image used to investigate colocalization between the
nuclear envelope and lactosylated QDs. Green: nuclear envelope. Red: QDs.

Figure 3.17. 3-D maximum project image used to investigate colocalization between the
Golgi apparatus and unconjugated QDs. Green: nuclear envelope. Red: QDs.
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Figure 3.18. 3-D maximum project image used to investigate colocalization between the
early endosomes and lactosylated QDs. Green: early endosomes. Red: QDs.

Figure 3.19. 3-D maximum project image used to investigate colocalization between the
early endosomes and unconjugated QDs. Green: early endosomes. Red: QDs.
QDs (Figure 3.20). These values are too close to determine if the lactosylation of QDs
caused a change in trafficking to the Golgi apparatus. M1 values for colocalization
between QDs and the nuclear envelope were 0.963 ± 0.019 and 0.860 ± 0.093 for nonlactosylated and lactosylated QDs, respectively. Again, these values are too close to
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accurately conclude lactose effectively targeted the QDs toward the nucleus. Manders’
values for colocalization between the QDs and the early endosomes were calculated as
0.304 ± 0.083 and 0.285 ± 0.114 for the non-lactosylated and lactosylated QDs,
respectively. These values also offered no further evidence that the lactosylated QDs
were trafficked differently than non-lactosylated QDs.
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Figure 3.20. Comparison of M1 Values. Graph showing M1 values and standard
deviation for each organelle.
3.5 Conclusion and Future Work
This work explored the possibility of using lactosylated QD vectors as non-viral
gene therapy vectors. Initial work was successful in optimizing water solubility
techniques, functionalization with PEG derivatives, and bioconjugation of lactose. The
ligand exchange solubilization produced QDs that were far more stable overtime than
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previously used polymer encapsulated QDs. Imparting a positive charge on the QDs
proved to be more difficult than previously expected. Similar work was done in the lab
previously in an attempt to impart positive charge on polymer-encapsulated QDs, but
inconclusive results were obtained in attempts to functionalize QDs with positive charge
using QDs solubilized with MUA. Analysis of the imaging data seems to conclude there
is not difference in trafficking between the lactosylated and non-lactosylated QDs. The
bleed through between the red and green channels didn’t allow for conclusive
colocalization to be determined. Comparison of M1 values between the lactosylated and
non-lactosylated QDs, even with the bleed over, are too similar to come to a conclusion.
Further work needs to be done optimizing the diamine reactions to produce an
overall positive charge on the QDs. A molecule such as poly-arginine could be used to
increase the overall positive charge. Intracellular trafficking experiments were completed
using both conventional and confocal microscopy but need to be revisited using a
different filter combination to produce usable results.
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